4//SEC Filing
Mathew Aby J. 4
Accession 0001628280-25-045017
CIK 0000834365other
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 5:30 PM ET
Size
5.0 KB
Accession
0001628280-25-045017
Insider Transaction Report
Form 4
Mathew Aby J.
EVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-10-09$27.36/sh−509$13,926→ 350,912 total
Footnotes (1)
- [F1]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0001556355
Filing Metadata
- Form type
- 4
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 14, 5:30 PM ET
- Size
- 5.0 KB